Inventor
SHINGO HANAOKA
Inventor
JP
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides20%
C12NMicroorganisms or enzymes20%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
C12YEnzymes5%
PatentTitleYear
12,509,507Fusion protein suitable for dissolving fibrin clot, and pharmaceutical composition containing said fusion protein202511,633,499Anti-TMEM-180 antibody, anticancer drug and cancer testing method202311,524,074Cancer-cell-specific anti-TMEM-180 monoclonal antibody, anticancer drug, and cancer testing method202211,192,956Antibody binding to TMEM132A, anticancer agent, and cancer test method2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to RIN INST INC (4)· patent assignee history
2021–2023Patents assigned to NAT CANCER CENTER JAPAN (2)· patent assignee history
2021–2025Based in JP· patent location history
2022–2025Patents assigned to NAT CANCER CT (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| RIN INST INC | 4 | 2021–2025 |
| NAT CANCER CENTER JAPAN | 2 | 2021–2023 |
| NAT CANCER CT | 2 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 4 | 2021–2025 |